rs115134980

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000203.5(IDUA):​c.1402+36T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 1,392,176 control chromosomes in the GnomAD database, including 19,452 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2402 hom., cov: 33)
Exomes 𝑓: 0.16 ( 17050 hom. )

Consequence

IDUA
NM_000203.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -3.42

Publications

10 publications found
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
IDUA Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
  • Scheie syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Hurler syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
  • Hurler-Scheie syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 4-1002980-T-C is Benign according to our data. Variant chr4-1002980-T-C is described in ClinVar as Benign. ClinVar VariationId is 255522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IDUANM_000203.5 linkc.1402+36T>C intron_variant Intron 9 of 13 ENST00000514224.2 NP_000194.2
IDUANM_001363576.1 linkc.1006+36T>C intron_variant Intron 8 of 12 NP_001350505.1
IDUANR_110313.1 linkn.1490+36T>C intron_variant Intron 9 of 13
IDUAXM_047415650.1 linkc.1402+36T>C intron_variant Intron 9 of 11 XP_047271606.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IDUAENST00000514224.2 linkc.1402+36T>C intron_variant Intron 9 of 13 2 NM_000203.5 ENSP00000425081.2

Frequencies

GnomAD3 genomes
AF:
0.175
AC:
26500
AN:
151524
Hom.:
2406
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.213
Gnomad AMI
AF:
0.172
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.166
Gnomad EAS
AF:
0.200
Gnomad SAS
AF:
0.302
Gnomad FIN
AF:
0.165
Gnomad MID
AF:
0.236
Gnomad NFE
AF:
0.154
Gnomad OTH
AF:
0.185
GnomAD2 exomes
AF:
0.157
AC:
5479
AN:
34990
AF XY:
0.169
show subpopulations
Gnomad AFR exome
AF:
0.183
Gnomad AMR exome
AF:
0.0620
Gnomad ASJ exome
AF:
0.132
Gnomad EAS exome
AF:
0.196
Gnomad FIN exome
AF:
0.144
Gnomad NFE exome
AF:
0.140
Gnomad OTH exome
AF:
0.153
GnomAD4 exome
AF:
0.160
AC:
199015
AN:
1240546
Hom.:
17050
Cov.:
36
AF XY:
0.163
AC XY:
98716
AN XY:
605004
show subpopulations
African (AFR)
AF:
0.220
AC:
5436
AN:
24710
American (AMR)
AF:
0.0888
AC:
1316
AN:
14828
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
2973
AN:
18962
East Asian (EAS)
AF:
0.157
AC:
4352
AN:
27658
South Asian (SAS)
AF:
0.291
AC:
16925
AN:
58144
European-Finnish (FIN)
AF:
0.175
AC:
5330
AN:
30434
Middle Eastern (MID)
AF:
0.201
AC:
961
AN:
4790
European-Non Finnish (NFE)
AF:
0.152
AC:
153171
AN:
1009998
Other (OTH)
AF:
0.168
AC:
8551
AN:
51022
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9325
18650
27975
37300
46625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5916
11832
17748
23664
29580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.175
AC:
26496
AN:
151630
Hom.:
2402
Cov.:
33
AF XY:
0.176
AC XY:
13040
AN XY:
74122
show subpopulations
African (AFR)
AF:
0.213
AC:
8806
AN:
41372
American (AMR)
AF:
0.124
AC:
1888
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
576
AN:
3464
East Asian (EAS)
AF:
0.200
AC:
1020
AN:
5098
South Asian (SAS)
AF:
0.301
AC:
1445
AN:
4798
European-Finnish (FIN)
AF:
0.165
AC:
1737
AN:
10516
Middle Eastern (MID)
AF:
0.229
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
0.154
AC:
10413
AN:
67794
Other (OTH)
AF:
0.184
AC:
388
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1142
2283
3425
4566
5708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
290
580
870
1160
1450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.146
Hom.:
219
Bravo
AF:
0.170
Asia WGS
AF:
0.251
AC:
867
AN:
3442

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mucopolysaccharidosis, MPS-I-H/S Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mucopolysaccharidosis, MPS-I-S Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mucopolysaccharidosis type 1 Benign:1
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hurler syndrome Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.2
DANN
Benign
0.11
PhyloP100
-3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115134980; hg19: chr4-996768; COSMIC: COSV56105910; COSMIC: COSV56105910; API